Journal
LABORATORY INVESTIGATION
Volume 94, Issue 1, Pages 89-97Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/labinvest.2013.127
Keywords
CEBP; C/EBP delta; chronic kidney disease; interstitial fibrosis; transcriptional regulation; vascular barrier
Categories
Funding
- Dutch Kidney foundation [C06.2198]
Ask authors/readers for more resources
CCAAT-enhancer-binding protein delta (C/EBP delta) is a transcription factor mainly known for its role in inflammation and apoptosis/proliferation. Considering that these are key processes in renal fibrosis, we hypothesized that C/EBP delta would potentiate renal fibrosis. In line with this hypothesis, C/EBP delta has recently been suggested to regulate the fibrotic response during glomerulonephritis. Here we determined the importance of C/EBP delta in the development of renal tubulointerstitial fibrosis by subjecting 8- to 12-week-old C/EBP delta-deficient mice and age-and sex-matched wild-type controls to the unilateral ureteral obstruction model. Mice were killed at 1, 3, or 7 days post surgery, and renal tissues were obtained for RNA, protein, and immunohistochemical analysis. We show that C/EBP delta deficiency resulted in a more profound fibrotic response as evident from enhanced tubular injury, collagen deposition in the interstitial area, and higher expression of transforming growth factor-beta. Moreover, we show that the increase in renal fibrosis in C/EBPd-deficient mice does not depend on an altered proliferation/apoptosis balance or on a differential inflammatory response in the obstructed kidney. In conclusion, our study provides direct evidence that C/EBP delta is a novel mediator of renal fibrosis. Modulating C/EBP delta expression could consequently be a potential antifibrotic strategy in patients with chronic kidney disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available